Priority Date: 28.06.02 (US 20020392350P)

Modified 2' and 3' -nucleoside prodrugs for treating flaviridae infections

  • Application ID: EP14169110
  • Status: EXAMINATION IN PROGRESS

Attorney

Employment test 1001 - 5000 employees
Company dna jones day
operating since 1893
1099.72
Headquarter in Cleveland and 38 offices
active in Legal Services

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Jones Day is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 188 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 28.06.2002 - Priority Date (US 20020392350P)
  • 05.11.2014 - Publication A1 (EP2799442)